HAI Book 2025 - Flipbook - Page 446
Thursday, January 16, 2025 - 11:00 am - 12:40 pm
Podium Session
SESSION IV: Neuropath II
CHAIRS: Keith Johnson, Christina Moloney
Thursday, January 16, 2025
11:00 am - 12:40 pm
SESSION IV
Neuropath II
Keith Johnson, Massachusetts General
Hospital, Boston, MA, USA
Christina Moloney, Mayo Clinic,
Jacksonville, FL, USA
11:00 am – 11:05 am
Session Overview
Chairs
Understanding the mechanisms of
11:05 am synaptic vesicle glycoprotein 2A change in
Alzheimer's disease
Association of [18F]Flortaucipir-PET and
plasma p-tau217 with tau neuropathology
11:20 am
in AD and other neurodegenerative
disorders
Tau-related cortical thinning is
11:35 am
concentrated in sulcal depths
Comparison of [3H]MK-6240 and [3H]AV1451 binding in relation to brain
11:50 am
concentrations of p-tau: A postmortem
biochemistry study
In vitro binding of the tau PET tracer
[3H]JSS20-183A and its comparison with
12:05 pm
PI-2620, T807 and PM-PBB3 in human
postmortem brain tissue
12:20 pm – 12:40 pm Discussion
HAI2025 - 446
Laetitia Lemoine, Perceptive, London, GB
Agathe Vrillon, University of California San
Francisco, San Francisco, CA, US
Samira Maboudian, Department of
Neuroscience, University of California,
Berkeley, Berkeley, CA, US
Tobey Betthauser, University of
Wisconsin-Madison, School of Medicine
and Public Health, Department of
Medicine, Madison, WI, US
Dinahlee Saturnino Guarino, Department
of Radiology, University of Pennsylvania,
Philadelphia, PA, US
